Загрузка...
Class II-associated invariant chain peptide as predictive immune marker in minimal residual disease in acute myeloid leukemia
The majority of patients with acute myeloid leukemia (AML) reach complete remission after high-dose chemotherapy. Still, half of these patients experience a relapse due to presence of minimal residual disease (MRD). Here we discuss the poor prognostic role of class II-associated invariant chain pept...
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353169/ https://ncbi.nlm.nih.gov/pubmed/25964856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.941737 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|